The US FDA is considering elevating patient engagement to a more visible position by establishing a central office for the programs.
The agency said in a Federal Register notice expected to be published March 14 that it is seeking...
FDA floats idea of central office to coordinate patient engagement for symbolic as well as practical reasons.
The US FDA is considering elevating patient engagement to a more visible position by establishing a central office for the programs.
The agency said in a Federal Register notice expected to be published March 14 that it is seeking...